These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 12036362

  • 1. Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin phosphate.
    Pettit GR, Grealish MP, Jung MK, Hamel E, Pettit RK, Chapuis JC, Schmidt JM.
    J Med Chem; 2002 Jun 06; 45(12):2534-42. PubMed ID: 12036362
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antineoplastic agents. 410. Asymmetric hydroxylation of trans-combretastatin A-4.
    Pettit GR, Toki BE, Herald DL, Boyd MR, Hamel E, Pettit RK, Chapuis JC.
    J Med Chem; 1999 Apr 22; 42(8):1459-65. PubMed ID: 10212132
    [Abstract] [Full Text] [Related]

  • 5. E-Combretastatin and E-resveratrol structural modifications: antimicrobial and cancer cell growth inhibitory beta-E-nitrostyrenes.
    Pettit RK, Pettit GR, Hamel E, Hogan F, Moser BR, Wolf S, Pon S, Chapuis JC, Schmidt JM.
    Bioorg Med Chem; 2009 Sep 15; 17(18):6606-12. PubMed ID: 19709889
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antineoplastic agents. 443. Synthesis of the cancer cell growth inhibitor hydroxyphenstatin and its sodium diphosphate prodrug.
    Pettit GR, Grealish MP, Herald DL, Boyd MR, Hamel E, Pettit RK.
    J Med Chem; 2000 Jul 13; 43(14):2731-7. PubMed ID: 10893310
    [Abstract] [Full Text] [Related]

  • 8. Novel combretastatin analogues endowed with antitumor activity.
    Simoni D, Romagnoli R, Baruchello R, Rondanin R, Rizzi M, Pavani MG, Alloatti D, Giannini G, Marcellini M, Riccioni T, Castorina M, Guglielmi MB, Bucci F, Carminati P, Pisano C.
    J Med Chem; 2006 Jun 01; 49(11):3143-52. PubMed ID: 16722633
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synthesis and structure-activity relationships of 3-aminobenzophenones as antimitotic agents.
    Liou JP, Chang JY, Chang CW, Chang CY, Mahindroo N, Kuo FM, Hsieh HP.
    J Med Chem; 2004 May 20; 47(11):2897-905. PubMed ID: 15139768
    [Abstract] [Full Text] [Related]

  • 12. Antineoplastic agents. 379. Synthesis of phenstatin phosphate.
    Pettit GR, Toki B, Herald DL, Verdier-Pinard P, Boyd MR, Hamel E, Pettit RK.
    J Med Chem; 1998 May 07; 41(10):1688-95. PubMed ID: 9572894
    [Abstract] [Full Text] [Related]

  • 13. Antineoplastic agents. 578. Synthesis of stilstatins 1 and 2 and their water-soluble prodrugs.
    Pettit GR, Thornhill A, Melody N, Knight JC.
    J Nat Prod; 2009 Mar 27; 72(3):380-8. PubMed ID: 19228038
    [Abstract] [Full Text] [Related]

  • 14. Antineoplastic agents. 515. Synthesis of human cancer cell growth inhibitors derived from 3,4-methylenedioxy-5,4'-dimethoxy-3'-amino-Z-stilbene.
    Pettit GR, Anderson CR, Gapud EJ, Jung MK, Knight JC, Hamel E, Pettit RK.
    J Nat Prod; 2005 Aug 27; 68(8):1191-7. PubMed ID: 16124759
    [Abstract] [Full Text] [Related]

  • 15. Antineoplastic agents 393. Synthesis of the trans-isomer of combretastatin A-4 prodrug.
    Pettit GR, Rhodes MR, Herald DL, Chaplin DJ, Stratford MR, Hamel E, Pettit RK, Chapuis JC, Oliva D.
    Anticancer Drug Des; 1998 Dec 27; 13(8):981-93. PubMed ID: 10335271
    [Abstract] [Full Text] [Related]

  • 16. Antineoplastic agents. 487. Synthesis and biological evaluation of the antineoplastic agent 3,4-methylenedioxy-5,4'-dimethoxy-3'-amino-Z-stilbene and derived amino acid amides.
    Pettit GR, Anderson CR, Herald DL, Jung MK, Lee DJ, Hamel E, Pettit RK.
    J Med Chem; 2003 Feb 13; 46(4):525-31. PubMed ID: 12570374
    [Abstract] [Full Text] [Related]

  • 17. Synthesis of a 2-aryl-3-aroyl indole salt (OXi8007) resembling combretastatin A-4 with application as a vascular disrupting agent.
    Hadimani MB, Macdonough MT, Ghatak A, Strecker TE, Lopez R, Sriram M, Nguyen BL, Hall JJ, Kessler RJ, Shirali AR, Liu L, Garner CM, Pettit GR, Hamel E, Chaplin DJ, Mason RP, Trawick ML, Pinney KG.
    J Nat Prod; 2013 Sep 27; 76(9):1668-78. PubMed ID: 24016002
    [Abstract] [Full Text] [Related]

  • 18. Further naphthylcombretastatins. An investigation on the role of the naphthalene moiety.
    Maya AB, Pérez-Melero C, Mateo C, Alonso D, Fernández JL, Gajate C, Mollinedo F, Peláez R, Caballero E, Medarde M.
    J Med Chem; 2005 Jan 27; 48(2):556-68. PubMed ID: 15658869
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and biological evaluation of fluoro analogues of antimitotic phenstatin.
    Ghinet A, Tourteau A, Rigo B, Stocker V, Leman M, Farce A, Dubois J, Gautret P.
    Bioorg Med Chem; 2013 Jun 01; 21(11):2932-40. PubMed ID: 23618708
    [Abstract] [Full Text] [Related]

  • 20. Synthesis, biological evaluation and molecular docking studies of resveratrol derivatives possessing curcumin moiety as potent antitubulin agents.
    Ruan BF, Lu X, Li TT, Tang JF, Wei Y, Wang XL, Zheng SL, Yao RS, Zhu HL.
    Bioorg Med Chem; 2012 Jan 15; 20(2):1113-21. PubMed ID: 22189271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.